Inter-atrial shunts—investigational devices that create a small pathway for blood to pass from the left to the right side of the heart in order to improve heart failure symptoms and outcomes—may be ...

Please provide your email address to receive an email when new articles are posted on . Interatrial shunt implant lowered HF hospitalization risk for patients with HFrEF vs. placebo. However, patients ...

Study shows no benefit for heart failure overall but suggests different effects in those with preserved versus reduced ejection fraction Patients with heart failure who had a small shunt inserted ...

BOSTON, MA—This week’s Technology and Heart Failure Therapeutics (THT) 2023 meeting featured more than a dozen talks on interatrial shunts to reduce left atrial pressures and volume overload in heart ...

10 patients enrolled with 100% implantation success Adona's adjustable interatrial shunt is designed so it can be modified post-implantation to provide a more adaptive and personalized lifetime ...

NORFOLK , Va. - It's an epidemic that affects more than six million people in the U.S., and doctors diagnose 800,000 new cases each year. "Heart failure is the number one cause of hospital admission ...

Corvia Medical has raised $55m to complete an ongoing clinical trial of its atrial shunt system for heart failure. The US-based company’s trial began in 2022 and is currently underway at more than 65 ...

Jimmy McMillan, 69, of West Columbia felt his health growing worse as his heart failure progressed. “I would have trouble just walking down to the mailbox and back without having to stop and catch my ...

Results from early clinical evaluation of the Alleviant System to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) was presented today as late-breaking ...